AOBiome Targets Atopic Dermatitis Niche With Bacteria-Based Drug
Executive Summary
While the atopic dermatitis market overall is crowded, the company sees a market opportunity for a drug that addresses both appearance and itching, as well as having favorable safety and ease of use.